3月24日,康诺亚(02162.HK)发布公告称,公司NewCo合作企业Ouro Medicines已与吉利德科学(简称“吉利德”,NASDQ:GILD)签署并购协议,吉利德将以并购方式收购Ouro Medicines。此次交易总金额可达21.75亿美元,包括16.75亿美元首付款(可按惯例调整)和最高5亿美元里程碑付款。 根据并购协议,作为Ouro Medicines的股东,交易完成后康诺亚将...
Source Link3月24日,康诺亚(02162.HK)发布公告称,公司NewCo合作企业Ouro Medicines已与吉利德科学(简称“吉利德”,NASDQ:GILD)签署并购协议,吉利德将以并购方式收购Ouro Medicines。此次交易总金额可达21.75亿美元,包括16.75亿美元首付款(可按惯例调整)和最高5亿美元里程碑付款。 根据并购协议,作为Ouro Medicines的股东,交易完成后康诺亚将...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.